CVE-2024-44837

Name: CVE-2024-44837
Creator: NVD / NIST
Published: 2024-09-06T14:15:12.517+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.4/10EPSS 0.29%

Last modified Jun 17, 2026

CVE-2024-44837 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.. EPSS estimates a 0.29% chance of exploitation in the next 30 days.

Description

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.

Metrics

CVSS 3.1

5.4/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS Probability

0.29%

21.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Deathbreak	Drug	1.0

References

https://kaput-raptorex-7c1.notion.site/drug-1-0-DOM-based-cross-site-scripting-fae620f769304f67a7488a961d048672Exploit, Third Party Advisory

Timeline

Published: Sep 6, 2024
Last Modified: Jun 17, 2026
Status: Analyzed

Frequently Asked Questions

What is CVE-2024-44837?

How severe is CVE-2024-44837?

CVE-2024-44837 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.29% probability of exploitation in the next 30 days.

How do I fix CVE-2024-44837?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2024-44837?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST